Health

Why Moderna’s shares rose 228.3% in the first half

What happened Modern (NASDAQ: MRNA) Shares soared 228.3% in the first half, according to data provided by S&P Global Market Intelligence, as the company advanced its COVID-19 vaccine through clinical studies and announced promising early data. Image source: Getty Images. Moderna became the first company to begin clinical trials with …

Read More »